Lack of relationship between plasma levels of escitalopram and QTc-interval length
Lack of relationship between plasma levels of escitalopram and QTc-interval length
About this item
Full title
Author / Creator
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title
Language
English
Formats
Publication information
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Subjects
More information
Scope and Contents
Contents
Despite safety concerns raised by the European Medicines Agency (EMA), evidence supporting QT-lengthening effects of escitalopram is far to be conclusive. We aimed to evaluate the relationship between escitalopram plasma levels (Escit-PL) and corrected QT-interval length (QTc-length) in 91 outpatients recruited from a hospital setting. Fifteen pati...
Alternative Titles
Full title
Lack of relationship between plasma levels of escitalopram and QTc-interval length
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1861605743
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1861605743
Other Identifiers
ISSN
0940-1334
E-ISSN
1433-8491
DOI
10.1007/s00406-016-0758-6
